Multiple Sclerosis: Neurorehabilitation and Symptomatic Treatment

被引:1
|
作者
Sailer, Michael [1 ,2 ,3 ]
Lindquist, Sabine [4 ,5 ]
Sickert, Almut [5 ]
Lamprecht, Juliane [3 ,5 ]
机构
[1] MEDIAN Kliniken, Neurol Rehabil Zentrum, Magdeburg, Germany
[2] MEDIAN Kliniken, Neurol Rehabil Zentrum, Flechtingen, Germany
[3] Otto Von Guericke Univ, Inst Neurorehabil, Magdeburg, Germany
[4] Pfeiffersche Stiftungen Magdeburg, Med Zentrums Erwachsene Behinderung, Magdeburg, Germany
[5] MEDIAN Klin, Neurol Rehabil Zentrum, Magdeburg, Germany
关键词
multiple sclerosis; inpatient rehabilitation; neurorehabilitation; DISEASE; DIAGNOSIS;
D O I
10.1055/a-0755-1398
中图分类号
R49 [康复医学];
学科分类号
100215 ;
摘要
Multiple sclerosis is the most common cause of non-traumatic disability in young adults. The following article addresses special features of multiple sclerosis in the context of neurological rehabilitation. The rehabilitative and symptomatic therapy of frequent symptoms and functional deficits are presented independently of the course of the disease. Rehabilitation in MS focuses on functional deficits in mobility, paresis, spasticity, ataxia, bladder dysfunction, fatigue, cognitive symptoms, depression and pain. The multimodal inpatient rehabilitation comprises aerobic training in MS- specific groups and interventions targeting individual deficits. Neuropsychological training, individual and group session on coping and adherence to therapy as well as advice on social issues and the evaluation of the work place situation complement the therapy options. The early age of onset of the disease often causes an early restriction of participation in working life. The restoration and maintenance of work ability is therefore an essential goal of neurological rehabilitation, as well as the organization of aftercare and the introduction of vocational rehabilitation services.
引用
收藏
页码:339 / 350
页数:12
相关论文
共 50 条
  • [21] Cognitive Deficits in Multiple Sclerosis: Recent Advances in Treatment and Neurorehabilitation
    Arseny A. Sokolov
    Petr Grivaz
    Riley Bove
    [J]. Current Treatment Options in Neurology, 2018, 20
  • [22] Cognitive Deficits in Multiple Sclerosis: Recent Advances in Treatment and Neurorehabilitation
    Sokolov, Arseny A.
    Grivaz, Petr
    Bove, Riley
    [J]. CURRENT TREATMENT OPTIONS IN NEUROLOGY, 2018, 20 (12)
  • [23] Indications for symptomatic treatment of spasticity in multiple sclerosis
    Lebrun, C
    [J]. REVUE NEUROLOGIQUE, 2001, 157 (8-9) : 1045 - 1050
  • [24] Prospective study of neurorehabilitation in multiple sclerosis
    Kidd, D
    Thompson, AJ
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1997, 62 (04): : 423 - 424
  • [25] Cannabis and cannabinoids for symptomatic treatment for people with multiple sclerosis
    Filippini, Graziella
    Minozzi, Silvia
    Borrelli, Francesca
    Cinquini, Michela
    Dwan, Kerry
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2022, (05):
  • [26] Dalfampridine in multiple sclerosis: From symptomatic treatment to immunomodulation
    Espejo, Carmen
    Montalban, Xavier
    [J]. CLINICAL IMMUNOLOGY, 2012, 142 (01) : 84 - 92
  • [27] Impact of neurorehabilitation on immune parameters in multiple sclerosis
    Rasova, K.
    Kalistova, H.
    Kucera, P.
    Juzova, O.
    Zimova, D.
    Medova, E.
    Martinkova, P.
    Dolezil, D.
    Jandova, D.
    Jandova, D.
    [J]. MULTIPLE SCLEROSIS, 2009, 15 (09): : S146 - S147
  • [28] Neurorehabilitation treatment of amyotrophic lateral sclerosis
    Orient-Lopez, F.
    Terre-Boliart, R.
    Guevara-Espinosa, D.
    Bernabeu-Guitart, M.
    [J]. REVISTA DE NEUROLOGIA, 2006, 43 (09) : 549 - 555
  • [29] Past, present and future of neurorehabilitation in multiple sclerosis
    Caceres, Fernando
    [J]. MULTIPLE SCLEROSIS, 2008, 14 : S27 - S27
  • [30] The effect of neurorehabilitation on gait in patients with multiple sclerosis
    Sidorenko, S.
    Kesslering, J.
    Luyckx, K.
    Gonzenbach, R.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 : 183 - 183